Answer:
RM-A can be both a positive and a negative regulator for Enzyme X
Explanation:
It is imperative to obtain more comprehensive information on the signaling pathways in order to assess the regulatory role of the RM-A molecule on X and Y enzymes.
Enzymes are modulated by molecules that are capable of increasing or reducing enzymatic activity, which are referred to as activators and inhibitors, respectively.
Fructose 2,6-bisphosphate is an essential allosteric regulator that activates phosphofructokinase 1 (PFK1) and thus is capable of increasing the glycolysis rate in response to insulin. On the other hand, an inhibitor may be a pharmaceutical drug used to compete with a substrate for binding to the active site of the enzyme. For instance, the methotrexate chemotherapy drug is known to be a competitive inhibitor.
